Choriogonadotropin

人绒促性素

Report date: 2025/07/14 17:48:58

Base Information

Drug NameChoriogonadotropin
Drug Alias NameN/A
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionOvarian follicle stimulantsLuteinizing hormone/Choriogonadotropin receptor modulators
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsHypogonadismAbortion, ThreatenedAbortion, Habitual +[7] 
Global Approved IndicationsHypogonadismAbortion, ThreatenedAbortion, Habitual +[7] 
Approved Indications in ChinaAbortion, ThreatenedAbortion, HabitualUterine Hemorrhage +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date1973/03/05
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesFresenius Kabi Manufacturing SaShaanxi Medicine Holding Group Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHypogonadismAbortion, ThreatenedAbortion, Habitual +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A